Compare ADMA Biologics Inc (ADMA) vs Zoom Video Communications, Inc. (ZM) Price & Performance

ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.

The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.

Zoom Communications (ZM) trades at $85.68, down 1.68% on the day, with a bearish technical outlook despite strong fundamentals. The stock shows robust profitability with 77.4% gross margins and 42% net income margin, while trading at attractive valuation multiples (P/E 12.5x, P/S 5.2x). Recent Q1 2026 earnings beat expectations, and the company continues AI-driven growth through acquisitions like Common Room and new product launches.

ZM presents a compelling value opportunity with significant upside to the $118.79 consensus price target, though technical weakness and competitive pressures from Microsoft and Google remain headwinds. The company's strong cash position ($7.7B) and strategic Anthropic investment provide additional upside catalysts, making it attractive for patient investors despite near-term bearish technical signals.